📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Mesenchymal Stromal Cell Therapy: After the Gold Rush. (2018)

First Author: Issa F

Attributed to: The TWO Study: A Phase II trial of regulatory T cells in renal transplantation - can we achieve sirolimus monotherapy? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1097/tp.0000000000001932

PubMed Identifier: 28858990

Publication URI: http://europepmc.org/abstract/MED/28858990

Type: Journal Article/Review

Volume: 102

Parent Publication: Transplantation

Issue: 1

ISSN: 0041-1337